GSK Investigational Site

Varese 21100

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Nasal Polyps

Studies at this site

• An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) — Completed
• Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2) — Completed